# Intrauterine Misoprostol Versus Intravenous Oxytocin Infusion During Cesarean Delivery

> **NCT03148574** · PHASE3 · COMPLETED · sponsor: **Assiut University** · enrollment: 240 (actual)

## Conditions studied

- Post Partum Hemorrhage

## Interventions

- **DRUG:** Misoprostol
- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT03148574
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-02
- **Primary completion:** 2019-09-15
- **Final completion:** 2019-12-15
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2021-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03148574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03148574, "Intrauterine Misoprostol Versus Intravenous Oxytocin Infusion During Cesarean Delivery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03148574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*